Us Fda Grants Breakthrough Therapy Designation To Zambons Cms I Neb In Patients With Ncfb

Zambon, A Multinational Pharmaceutical Company, Announced That The Us Food And Drug Administration (Fda) Has Granted Breakthrough Therapy Designation To Colistimethate Sodium Powder For Nebulization Solution (Cms I-Neb) For The Reduction In The Incidence Of Pulmonary Exacerbations In Adult Patients With Non-Cystic Fibrosis Bronchiectasis (Ncfb) Colonized With P. Aeruginosa. Ncfb Is A Chronic, Progressive, And Irreversible Respiratory Disease. There Are No Approved Inhaled Treatments Currently Available For Patients With Bronchiectasis And Chronic P. Aeruginosa Colonization.The Breakthrough Therapy Designation Is Supported By Data From The Phase 3 Promis - I Study, Which Showed That Cms I-Neb Significantly Reduced The Annual Rate Of Exacerbations In Patients With Ncfb And P. Aeruginosa Chronic Infection, The Primary Endpoint Of The Trial. In Addition, The Trial Met Important Secondary Endpoints, Including Reduction Of Severe Exacerbations And Prolongation Of Time To First Exacerbation Compared To Placebo, And Also Improvement In Quality Of Life (Qol). The Treatment Was Demonstrated To Be Well Tolerated With Adverse Events Similar Between Groups. Data From The Phase 3 Trial Were Most Recently Presented At The European Respiratory Society (Ers) International Congress In September 2021.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!